A 45-year-old man with rheumatoid arthritis is initiated on tacrolimus (a calcineurin inhibitor). After 3 weeks of therapy, he develops progressive tremor, headache, and altered mental status. Which investigation is most appropriate to confirm the suspected adverse effect?